A New Alzheimer's Drug Brings Hope and Controversy

The FDA this week approved the first new Alzheimer's treatment in nearly 20 years. But it almost didn't make it to market. WSJ's Joseph Walker untangles the complex story behind the drug Aduhelm and why its approval is raising questions. Learn more about your ad choices. Visit megaphone.fm/adchoices